The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS).
 
Myong Cheol Lim
No Relationships to Disclose
 
Ji Hyun Kim
No Relationships to Disclose
 
Boram Park
No Relationships to Disclose
 
Jaekyung Bae
No Relationships to Disclose
 
Jung-Yun Lee
Honoraria - AstraZeneca; Genmab; Merck Serono; MSD; Regeneron; Seagen
Consulting or Advisory Role - Abbvie (Inst); Advenchen Laboratories (Inst); Alkermes (Inst); Ascendis Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); BerGenBio (Inst); bms (Inst); CanariaBio (Inst); Cellid (Inst); CKD pharm (Inst); Clovis Oncology (Inst); Corcept Therapeutics (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Eisai (Inst); genemedicine (Inst); Genmab (Inst); GI Innovation (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Janssen Oncology (Inst); Kelun (Inst); Merck Serono (Inst); Merck Serono (Inst); MSD; Novartis (Inst); onconic therapeutics (Inst); Ono Pharmaceutical (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst); Sutro Biopharma (Inst); Synthon (Inst); Takeda (Inst); Torl Biotherapeutics (Inst); Zymeworks (Inst)
Speakers' Bureau - AstraZeneca; Eisai; MSD; Roche; Takeda
Research Funding - Ascendis Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (Inst); Immunogen (Inst); Janssen Oncology (Inst); Merck (Inst); Mersana (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); OncoQuest Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); Synthon (Inst); Takeda (Inst)
 
Heon Jong Yoo
No Relationships to Disclose
 
Yun Hwan Kim
No Relationships to Disclose
 
Ga Won Yim
No Relationships to Disclose
 
Jae-Yun Song
No Relationships to Disclose
 
Yong Jung Song
No Relationships to Disclose
 
Suk-Joon Chang
No Relationships to Disclose
 
Dae Hoon Jeong
No Relationships to Disclose
 
Dae-Yeon Kim
No Relationships to Disclose
 
Ki Hyung Kim
No Relationships to Disclose
 
Ju-Won Roh
No Relationships to Disclose
 
Jae-Kwan Lee
No Relationships to Disclose
 
Sang-Soo Seo
No Relationships to Disclose
 
Sang-Yoon Park
No Relationships to Disclose